Related Experiment Videos
Modulation of hematopoiesis by lymphocyte membrane-derived components
1Department of Medicine, University of Connecticut Health Center, Farmington 06030.
Leukemia
|April 1, 1994
Summary
Interferon-gamma (IFN-gamma) suppresses erythropoiesis by inhibiting burst-forming units-erythroid (BFU-E) proliferation. However, IFN-gamma increases membrane-bound erythroid burst-promoting activity (mBPA) on leukemic cells, suggesting complex regulatory roles.
Area of Science:
- Hematology
- Immunology
- Cell Biology
Background:
- Membrane-bound erythroid burst-promoting activity (mBPA) is crucial for erythropoiesis, found on B-cells and T-cells.
- Leukemic A-1 cell lines and normal B-cells express mBPA, which can be targeted by antibodies like D3A4.
- Erythropoiesis is regulated by various factors, including cytokines and cell-surface interactions.
Purpose of the Study:
- To investigate the effect of interferon-gamma (IFN-gamma) on erythroid burst-promoting activity (mBPA) and erythropoiesis.
- To elucidate the role of IFN-gamma in modulating BFU-E proliferation in the presence of leukemic cells.
- To explore the relationship between IFN-gamma, mBPA expression, and vesicle shedding in B-cells.
Main Methods:
- In vitro culture of normal human bone marrow cells with and without A-1 cells.
- Treatment with recombinant human erythropoietin (rHuEpo) and IFN-gamma.
- Flow cytometry (FACS) analysis to assess surface mBPA expression on A-1 cells.
Main Results:
- IFN-gamma significantly suppressed BFU-E proliferation in normal human bone marrow cultures.
- This suppression occurred both independently and in the presence of A-1 leukemic cells.
- FACS analysis showed that IFN-gamma enhanced the surface expression of mBPA on A-1 cells.
Conclusions:
- IFN-gamma exerts an inhibitory effect on erythropoiesis in vitro, impacting BFU-E proliferation.
- Despite suppressing proliferation, IFN-gamma upregulates mBPA on leukemic cells, indicating a complex regulatory mechanism.
- The findings suggest that IFN-gamma's role in erythropoiesis involves intricate modulation of mBPA and potentially membrane vesicle shedding.